Profund Advisors’s Lexicon Pharmaceuticals LXRX Stock Holding History

Profund Advisors’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1,812	Closed	-$12K	–	1507
2015 Q1	$12K	Buy	1,812 +184	+11%	+$1.26K	﹤0.01%	1529
2014 Q4	$10K	Sell	1,628 -31	-2%	-$250	﹤0.01%	1437
2014 Q3	$16K	Sell	1,659 -1,750	-51%	-$18.7K	﹤0.01%	1307
2014 Q2	$38K	Buy	3,409 +66	+2%	+$709	﹤0.01%	1543
2014 Q1	$40K	Buy	3,343 +1,309	+64%	+$16.7K	﹤0.01%	1580
2013 Q4	$26K	Buy	2,034 +363	+22%	+$5.78K	﹤0.01%	1685
2013 Q3	$28K	Buy	1,671 +55	+3%	+$922	﹤0.01%	1635
2013 Q2	$25K	Buy	+1,616	New	+$24.6K	﹤0.01%	1375

Other funds holding LXRX

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Masters Capital Management Atlanta, Georgia $677M AUM 57.21% 1-Year Est. Return

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return